Value-Based Purchasing: Balancing Clinical Outcomes and Hospital Costs

Hospitals today face one of the most difficult balancing acts in healthcare.

Every day, clinical leaders identify technologies capable of improving patient outcomes, reducing caregiver burden, and advancing the standard of care. At the same time, supply chain leaders are tasked with controlling costs, standardizing purchases, ensuring contract compliance, and protecting already razor-thin operating margins.

These priorities are often portrayed as competing interests. They aren’t.

The best health systems understand that outstanding patient care and financial stewardship should reinforce—not oppose—one another.

Why Great Technologies Sometimes Move Slowly

One of the most common misconceptions in healthcare is that if a technology demonstrates better clinical outcomes, adoption should be straightforward.

Anyone who has introduced a new medical technology knows that isn’t how hospitals operate.

Before a single purchase order is issued, hospitals often evaluate:

These aren’t unnecessary obstacles. They’re safeguards designed to ensure that every purchasing decision delivers long-term value for patients, providers, and the organization.

Looking Beyond Acquisition Cost

Healthcare has evolved beyond asking, “What does this product cost?” Today’s question is:

“What does this product save?”

For critical care technologies, the purchase price represents only a fraction of the total economic picture.

Hospital leaders increasingly evaluate:

A technology that reduces several of these costs simultaneously may provide a far greater return on investment than one with a lower acquisition price.

This is the essence of value-based purchasing.

The Hidden Cost of Manual Processes

Few areas of critical care illustrate this more clearly than prone positioning.

For more than a decade, prone therapy has been recognized as an evidence-based standard of care for patients with moderate to severe respiratory complications. Yet despite overwhelming clinical support, many eligible patients are never proned—or are proned later than recommended.

The reason is rarely a lack of clinical knowledge. It is the operational burden of manual execution.

Traditional manual proning often requires:

• Five to seven highly trained caregivers
• Significant coordination across multiple departments
• Temporary diversion of bedside staff from other critically ill patients
• Concerns regarding accidental extubation or line dislodgement
• Increased caregiver lifting and musculoskeletal injury risk
• Variable execution from one shift to the next

These operational realities create friction that delays therapy and contributes to inconsistent utilization.

Those hidden costs rarely appear on an invoice—but they are paid every day.

Automation Changes the Value Equation

At Turn Medical, we believe automation should remove barriers to evidence-based care.

The Pronova-O₂® Automated Prone Therapy System was designed not simply to automate patient rotation, but to fundamentally improve how hospitals deliver prone therapy.

By replacing a labor-intensive manual process with controlled mechanical precision, hospitals gain benefits that extend well beyond the bedside.

Potential advantages include:

• Earlier initiation of prone therapy
• Consistent execution regardless of staffing availability
• Reduced caregiver lifting requirements
• Improved staff safety
• Standardized workflows
• Better utilization of highly trained ICU personnel
• Increased confidence in delivering evidence-based care

For supply chain leaders, this represents something equally important:  a technology capable of improving both clinical outcomes and operational efficiency.

Building a Strong Value Analysis Case

Every successful Value Analysis Committee presentation tells the same story.

Not simply:

“Our technology is clinically better.”

Instead:

“Our technology improves clinical outcomes while reducing operational burden and creating measurable financial value.”

That requires demonstrating evidence across three domains.

Clinical Value

• Does the technology improve patient outcomes?
• Is it supported by published literature?
• Does it align with clinical guidelines?

Operational Value

• Does it simplify workflows?
• Does it reduce staffing requirements?
• Does it improve consistency?
• Does it decrease caregiver injuries? 

Financial Value

• Can it reduce ICU costs?
• Can it improve throughput?
• Can it reduce preventable complications?
• Can it decrease indirect labor costs?
• Does it improve overall return on investment?

When all three align, innovation becomes significantly easier to justify.

The Most Successful Hospitals Think Differently

Progressive healthcare organizations no longer evaluate technology solely by asking:

“What does this cost?”

Instead, they ask:

• What operational problem does this solve?
• How does it improve patient care?
• Does it protect our caregivers?
• Will it help us deliver evidence-based medicine more consistently?
• What are the costs of continuing to do things the way we’ve always done them?

These questions recognize that innovation is not an expense, but rather an investment in better healthcare delivery.

Moving Innovation Forward Together

At Turn Medical, we recognize that bringing new technology into a hospital requires more than a great product. It requires collaboration:

• Clinicians understand the patient’s needs.
• Supply chain understands procurement strategy.
• Finance understands organizational sustainability.
• Value Analysis Committees ensure that innovation delivers measurable value.

Our role is to support all of them by providing the clinical evidence, economic data, operational insights, and implementation support necessary to make informed decisions.

Because the goal isn’t simply to introduce another piece of equipment. It’s to help hospitals deliver safer, more efficient, and more consistent care while responsibly managing the resources entrusted to them.

When clinical excellence and financial stewardship move in the same direction, everyone benefits: patients, caregivers, hospitals, and the communities they serve.